Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis

Clinical and Experimental Immunology

Volumn 110, Issue 2, 1997, Pages 324-328

  Van Der Vliet, H J J ^a   Wever, P C ^a   Van Diepen, F N J ^a   Yong, S L ^a   Ten Berge, I J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Apoptosis; Bax; Bcl 2; Fas; Leucocyte subsets

Indexed keywords

FAS ANTIGEN; PROTEIN BAX;

ADULT; APOPTOSIS; ARTICLE; CELL SURVIVAL; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030774154     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.tb08335.x     Document Type: Article

References (30)

1. Kerr JFR, Wyllie AH, Curie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-57.
2. Cohen JJ. Apoptosis. Immunol Today 1993; 14:126-30.
3. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic control on cell death. Cell 1993; 74:777-9.
4. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995; 13:513-43.
5. Bakhshi A, Jensen JP, Goldman P et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41:899-906.
6. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985; 82:7439-43.
7. Hockenherry D, Nunez G, Milliman C et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334-6.
8. Krajewski S, Krajewska M, Shabaik A et al. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994; 145:323-36.
9. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609-19.
10. Henderson S, Rowe M, Gregory C et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65:1107-15.
11. Nunez G, London L, Hockenbery D et al. Deregulated bcl-2 gene expression selectively prolongs survival of growth-factor deprived hemopoietic cell lines. J Immunol 1990; 144:3602-10.
12. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335:440-2.
13. Itoh N, Yonehara S, Ischii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-43.
14. Oehm A, Behrmann I, Falk W et al. Purification and molecular cloning of the APO-I cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 1992; 267:10709-15.
15. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995; 16:569-74.
16. Trauth BC, Klas C, Peters AMJ et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245:301-5.
17. Savill JS, Wylli AH, Henson JE et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by the macrophage. J Clin Invest 1989; 83:865-75.
18. Whyte MKB, Megher LC, MacDermot J et al. Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 1993; 150:5124-34.
19. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinflammatory cytokines. J Immunol 1991; 147:3408-12.
20. Iwai K, Miyawaki T, Takizawa T et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes and neutrophils. Blood 1994; 84:1201-8.
21. Koopman G, Reutelingsperger CPM, Kuijten GAM et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84:1415-20.
22. Lindhout E, Lakeman A, de Groot C. Follicular cells inhibit apoptosis in human B lymphocytes by a rapid and irreversible blockade of preexisting endonuclease. J Exp Med 1995; 181:1985-95.
23. + T lymphocytes during HIV infection. J Immunol 1996; 156:2282-93.
24. McConkey DJ, Chandra J, Wright S et al. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 to Bax. J Immunol 1996; 156:2624-30.
25. Strasser A, Harris AW, Huang DCS et al. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995; 14:6136-47.
26. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151:621-7.
27. Schröter M, Lowin B, Borner C et al. Regulation of Fas (Apo-1/CD95)-and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2. Eur J Immunol 1995; 25:3509-19.
28. Owen-Schaub LB, Yonehara S, Crump WL III et al. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992; 140:197-205.
29. Liles WC, Kiener PA, Ledbetter JA et al. Differential expression of Fas (CD95) and Fas Ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 1996; 184:429-40.
30. Le Deist F, Emile J-F, Rieux-Laucat F et al. Clinical immunological, and pathological consequences of Fas-deficient conditions. Lancet 1996; 348:719-23.